Endurant Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-165,404
Closed -$1.51M 72
2021
Q4
$1.51M Buy
+165,404
New +$1.51M 0.36% 47
2018
Q3
Sell
-8,824
Closed -$343K 78
2018
Q2
$343K Buy
+8,824
New +$343K 0.15% 60
2015
Q1
Sell
-58,100
Closed -$584K 99
2014
Q4
$584K Buy
+58,100
New +$584K 0.23% 77